Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Subscriber Content

China Pharmaceutical Group Pays $1.2 Billion for Robust Sun Holdings

publication date: Jun 27, 2012

China Pharmaceutical Group will pay $1.2 billion to acquire Robust Sun Holdings Ltd., a company that makes drugs for CNS diseases. The transaction will add to China Pharma’s presence in finished drugs and reduce its focus on intermediates and APIs. China Pharma will purchase Robust Sun from Joyful Horizon Ltd. All three entities are affiliated with Hony Capital, the Hong Kong-headquartered PE firm that is the largest in Asia. More details....

Stock Symbol: (HK: 1093)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.If you're not a subscriber why not subscribe today?